---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-130207"
form_type: "8-K"
ticker: "PROK"
cik: "0001850270"
company_name: "PROKIDNEY CORP."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T19:56:18.572301+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ProKidney to acquire two Winston-Salem buildings for $22.5M for rilparencel manufacturing

## Summary
- Purchase price of $22.5 million in cash for two buildings totaling ~180,000 sq ft.
- Buildings will support manufacturing operations for lead product candidate rilparencel.
- Transaction expected to close by end of November 2024, subject to customary conditions.
- Company currently occupies portions of the buildings under existing leases.
- Agreement contains customary representations; no financing contingency disclosed.

## SEC filing metadata
- accession: 0000950170-24-130207
- form_type: 8-K
- ticker: PROK
- cik: 0001850270
- company_name: PROKIDNEY CORP.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850270/000095017024130207/0000950170-24-130207-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850270/000095017024130207/prok-20241120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-130207
- JSON: https://secwatch.observer/filing/0000950170-24-130207.json
- Plain text: https://secwatch.observer/filing/0000950170-24-130207.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.